Asset Details
Do you wish to reserve the book?
116 Dietetic management of an infant with methylmalonyl-CoA mutase0 deficiency (MMAmut0) and hepatoblastoma pre and post liver transplantation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
116 Dietetic management of an infant with methylmalonyl-CoA mutase0 deficiency (MMAmut0) and hepatoblastoma pre and post liver transplantation
Do you wish to request the book?
116 Dietetic management of an infant with methylmalonyl-CoA mutase0 deficiency (MMAmut0) and hepatoblastoma pre and post liver transplantation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
116 Dietetic management of an infant with methylmalonyl-CoA mutase0 deficiency (MMAmut0) and hepatoblastoma pre and post liver transplantation
2019
Overview
BackgroundMorbidity remains high in MMAmut0 patients. Liver transplantation can decrease metabolic decompensation episodes and organ damage whilst improving quality of life (QOL).Case reportAn infant was prospectively managed as family history of MMAmut0, and confirmed postnatally. Bilateral dysplastic multicystic kidneys were diagnosed after birth and hepatoblastoma at 4 months. He underwent liver transplant age 6 months for tumour removal and MMA management.Pre-transplantDue to low albumin (<20 g/L), poor weight gain (0.4th-2nd to < 0.4th centile), protein was increased, 2 to 2.4 g/kg/d (WHO 2007, safe intake (SI) 1.77 g/kg/d), energy 120 to 140kcal/kg/d. He fed orally with NG top-ups. Poor feed tolerance necessitated a hydrolysed feed. Parenteral nutrition (PN) was required twice because of vomiting. Age 12 weeks protein was decreased, 1.85 g/kg/d as ammonia remained high (120-148umol/L). He thrived (weight, length 25th -50thcentile). Median plasma MMA (pMMA) was 134umol/L (range 44.2-230), (ref range 0-0.29).Post-transplantPN matched pre-transplant protein and energy intakes. He recommenced hydrolysed feed, via NGT and orally. After 3 months pMMA remained elevated, median 125umol/L (range 76.9- 169) protein was reduced to 1.5 g/kg/d (SI 1.14 g/kg/d) and is unchanged 1year post-transplant. All feeds are taken orally.ConclusionEpisodes of metabolic decompensation markedly decreased. Parents report QOL improved. Protein remains restricted.
Publisher
BMJ Publishing Group LTD
Subject
